2011
DOI: 10.1088/1757-899x/18/19/192019
|View full text |Cite
|
Sign up to set email alerts
|

Porous Hydroxyapatite Bioceramic Scaffolds for Drug Delivery and Bone Regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 11 publications
1
7
0
1
Order By: Relevance
“…The latter describes that with increasing PF concentration less area is available for the gas to develop inside the polymer matrix, which results in a smaller average size of the gas bubbles. Interestingly, the observed pore sizes are in accordance with those reported both for PU scaffolds produced via different manufacturing methods such as salt leeching (250 µm [ 64 ]) and gas foaming (60–300 µm [ 100 ]) and for systems produced via HME but using Eudragit ® as the polymer matrix (200 µm [ 101 ]).…”
Section: Resultssupporting
confidence: 85%
“…The latter describes that with increasing PF concentration less area is available for the gas to develop inside the polymer matrix, which results in a smaller average size of the gas bubbles. Interestingly, the observed pore sizes are in accordance with those reported both for PU scaffolds produced via different manufacturing methods such as salt leeching (250 µm [ 64 ]) and gas foaming (60–300 µm [ 100 ]) and for systems produced via HME but using Eudragit ® as the polymer matrix (200 µm [ 101 ]).…”
Section: Resultssupporting
confidence: 85%
“…The in vitro drug release were carried out on the drug loaded discs for both porous n-HAp and porous n-HAp/MWCNTs after subjecting them to a freeze drying (liophilization).And then such discs were immersed in amber glass vials containing a freshly prepared phosphate buffer solution with pH(6.8) and then placed in a shaker water bath with an adjusted temperature at 37ᴼC at different time intervals (1,2,3,4,6,8,24,48,69,144,192 hrs.) 2ml drug samples were withdrawn from such examined samples and immediately replaced with 2ml of donor phosphate buffer solution (pH 6.8) at each time intervals and for 8 days, in order to estimate the concentration and rate of drug release from drug loaded examined pellets at those particular time periods using UV-visible spectrophotometer at 271nm.…”
Section: Follow-up Of the Ciprofloxacin Releasementioning
confidence: 99%
“…In addition, high doses of drugs are necessary to get the desired effect. The use of local drug delivery as rout of administrations is An alternative approach able to release drug in a controlled way [1]. Therefore, the advantages of local antibiotic administration; high local levels with low systemic toxicity are nowadays recognized.…”
Section: Introductionmentioning
confidence: 99%
“…Materials used for drug delivery systems, span across various classes of biocompatible materials, including polymers such as synthetic polyorthoesters, poloaxmers, polyphosphazenes and natural polymers such as alginates and chitosan [19]. Other materials include inorganic materials such as hydroxyapatite and silica dioxide [20,21].…”
Section: Chapter 2 Literature Review 21 Drug Delivery Systemsmentioning
confidence: 99%